Esperion Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $152k | 57k | 2.68 |
| 2023-12-31 | $118k | 39k | 2.99 |
| 2023-09-30 | $21k | 22k | 0.98 |
| 2023-06-30 | $24k | 17k | 1.39 |
| 2023-03-31 | $23k | 14k | 1.59 |
| 2022-12-31 | $236k | 38k | 6.23 |
| 2022-06-30 | $69k | 11k | 6.37 |
| 2021-03-31 | $637k | 23k | 28.04 |
| 2020-12-31 | $301k | 12k | 26.04 |
| 2020-09-30 | $331k | 8.9k | 37.22 |
| 2020-06-30 | $255k | 5.0k | 51.36 |
| 2019-12-31 | $237k | 4.0k | 59.62 |
| 2019-06-30 | $235k | 5.1k | 46.44 |
| 2018-09-30 | $297k | 6.7k | 44.33 |
| 2017-06-30 | $241k | 5.2k | 46.35 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates